The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2521–2544 of 3,535
Harbinger Health has secured **$100 million** in its latest funding round, unveiling its new **Resolve** platform aimed at enhancing cancer detection through li...
Anavex Life Sciences Corp. has revealed significant findings supporting the **mechanistic rationale** for its orally administered drug, **blarcamesine**, as a t...
Ligand Pharmaceuticals has announced that its partner, Travere Therapeutics, has received FDA approval for **FILSPARI® (sparsentan)**, the first and only medica...
Tiziana Life Sciences has announced the acceptance of a late-breaking poster detailing its Phase 2a study of **intranasal foralumab**, a fully human anti-CD3 mo...
Researchers have developed a **composite SASP Score** that quantifies the burden of senescent cells in the body by analyzing proteomic data from blood samples....
Researchers at Scripps Research have identified a novel approach to mitigate **chronic inflammation** associated with autoimmune diseases and aging without sign...
Asgard Therapeutics has announced the appointment of Prof. Dr. Wolfram Brugger as Chief Medical Officer, signaling a strategic move to advance their lead asset,...
PannTheraPi has made significant strides in its clinical and strategic development, highlighted by the submission of a regulatory dossier to initiate a Phase 2a...
PannTheraPi has filed a regulatory submission to initiate a **Phase 2a trial** for its drug candidate **PTI5803**, targeting **focal cortical dysplasia (FCD)**,...
The FDA has granted **Fast Track Designation** to **Daretabart (hu1418K322A)**, a novel anti-GD2 monoclonal antibody developed by Renaissance Pharma Limited for...
Researchers at the Ecole Polytechnique Fédérale de Lausanne have uncovered a previously overlooked mechanism in mitochondrial biology termed **"mitochondrial pe...
Research from the University of East Anglia has revealed that social interactions significantly influence gut microbiome composition, as demonstrated in a study...
**Recent findings reveal that public restroom hygiene concerns may be misdirected, with high-touch surfaces posing greater risks than toilet seats. Research led...
A nationwide cohort study conducted in Denmark has revealed that **non-selective beta-blocker eye drops (timolol)** do not significantly increase the risk of fa...
**Ballad Health's Appalachian Highlands Care Network has been awarded the Innovators Award by Modern Healthcare for its transformative approach to rural healthc...
XORTX Therapeutics has successfully acquired the **VB4-P5** renal anti-fibrotic program from Vectus Biosystems, a move that positions the company to address sig...
Cellectis has announced significant interim results from Allogene Therapeutics’ pivotal ALPHA3 trial evaluating **cema-cel**, an allogeneic CAR-T therapy for **...
Cellectis has highlighted the interim futility analysis from Allogene Therapeutics regarding the pivotal ALPHA3 trial, which evaluates cema-cel as a first-line...
Sana Biotechnology, Inc. has announced a strategic collaboration with Mayo Clinic to expedite the development of **SC451**, a hypoimmune-modified pancreatic isl...
Revolution Medicines has announced a dual public offering aimed at raising **$1 billion** through **$750 million** in common stock and **$250 million** in conve...
Kailera is poised to enter the public market with a Nasdaq IPO aimed at raising up to **$528.5 million** to further develop its **GLP-1 assets** targeting obesi...
LifeLabs, a prominent provider of medical diagnostic services in Canada, is celebrating National Medical Laboratory Week (NMLW) by emphasizing the critical role...
A recent study highlights the potential of **nucleoside reverse transcriptase inhibitors (NRTIs)**, originally developed for HIV treatment, to mitigate biologic...
The longevity market is undergoing a significant transformation, with projections indicating growth from **$27.61 billion in 2025 to $67.03 billion by 2035**, d...
